# Study in Healthy Volunteers to Document Safety and Tolerability of Increasing Doses Pemirolast

> **NCT02517372** · PHASE1 · COMPLETED · sponsor: **RSPR Pharma AB** · enrollment: 24 (actual)

## Conditions studied

- Healthy Volunteers

## Interventions

- **DRUG:** CRD007

## Key facts

- **NCT ID:** NCT02517372
- **Lead sponsor:** RSPR Pharma AB
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-10
- **Primary completion:** 2014-12
- **Final completion:** 2014-12
- **Target enrollment:** 24 (ACTUAL)
- **Last updated:** 2015-08-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02517372

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02517372, "Study in Healthy Volunteers to Document Safety and Tolerability of Increasing Doses Pemirolast". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT02517372. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*